Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities
Provided By GlobeNewswire
Last update: Jan 13, 2025
Company achieved significant commercial progress in 2024, finishing with total U.S. net product sales revenue of approximately $319 million (unaudited)
Company reaffirms peak U.S. net IBSRELA sales revenue of greater than $1 Billion
Read more at globenewswire.comNASDAQ:ARDX (4/30/2025, 2:03:05 PM)
5.485
+0.04 (+0.64%)
Find more stocks in the Stock Screener
